A detailed history of Fiera Capital Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fiera Capital Corp holds 1,192,429 shares of EW stock, worth $78.1 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,192,429
Previous 1,192,429 -0.0%
Holding current value
$78.1 Million
Previous $110 Million -0.0%
% of portfolio
0.36%
Previous 0.36%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$84.3 - $94.31 $3.45 Million - $3.86 Million
40,926 Added 3.55%
1,192,429 $110 Million
Q1 2024

Aug 22, 2024

SELL
$72.54 - $95.56 $2.97 Million - $3.91 Million
-40,926 Reduced 3.43%
1,151,503 $110 Million
Q1 2024

May 01, 2024

BUY
$72.54 - $95.56 $19 Million - $25.1 Million
262,439 Added 29.52%
1,151,503 $110 Million
Q4 2023

Aug 22, 2024

BUY
$61.71 - $77.76 $13.1 Million - $16.5 Million
212,687 Added 31.45%
889,064 $67.8 Million
Q4 2023

Feb 08, 2024

BUY
$61.71 - $77.76 $13.1 Million - $16.5 Million
212,687 Added 31.45%
889,064 $67.8 Million
Q3 2023

Aug 22, 2024

SELL
$69.28 - $93.38 $35.8 Million - $48.2 Million
-516,052 Reduced 43.28%
676,377 $46.9 Million
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $8.29 Million - $11.2 Million
119,676 Added 21.5%
676,377 $46.9 Million
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $3.39 Million - $3.93 Million
41,689 Added 8.09%
556,701 $52.5 Million
Q1 2023

Apr 26, 2023

SELL
$74.26 - $84.51 $1.29 Million - $1.47 Million
-17,428 Reduced 3.27%
515,012 $42.6 Million
Q4 2022

Feb 08, 2023

BUY
$68.3 - $87.44 $9.7 Million - $12.4 Million
141,953 Added 36.35%
532,440 $39.7 Million
Q3 2022

Nov 03, 2022

BUY
$82.37 - $107.29 $2.01 Million - $2.62 Million
24,386 Added 6.66%
390,487 $32.3 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $1.74 Million - $2.58 Million
20,107 Added 5.81%
366,101 $34.8 Million
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $6.85 Million - $8.62 Million
-67,192 Reduced 16.26%
345,994 $40.7 Million
Q4 2021

Feb 08, 2022

BUY
$106.37 - $130.68 $9 Million - $11.1 Million
84,644 Added 25.76%
413,186 $53.5 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $31.8 Million - $37.9 Million
309,131 Added 1592.56%
328,542 $37.2 Million
Q2 2021

Aug 11, 2021

SELL
$83.84 - $104.76 $312,974 - $391,069
-3,733 Reduced 16.13%
19,411 $1.34 Million
Q1 2021

May 11, 2021

SELL
$78.68 - $90.67 $21.5 Million - $24.8 Million
-273,800 Reduced 92.21%
23,144 $1.94 Million
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $8.79 Million - $11.2 Million
122,643 Added 70.36%
296,944 $27.1 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $385,065 - $501,118
5,731 Added 3.4%
174,301 $13.9 Million
Q2 2020

Aug 07, 2020

BUY
$57.54 - $76.95 $8.91 Million - $11.9 Million
154,789 Added 1123.21%
168,570 $11.7 Million
Q1 2020

May 08, 2020

BUY
$52.41 - $81.0 $343,233 - $530,469
6,549 Added 90.56%
13,781 $2.6 Million
Q4 2019

Feb 06, 2020

SELL
$71.7 - $82.09 $67,613 - $77,410
-943 Reduced 11.54%
7,232 $1.69 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $8,924 - $10,937
145 Added 1.81%
8,175 $1.8 Million
Q2 2019

Aug 12, 2019

SELL
$55.74 - $64.41 $21,404 - $24,733
-384 Reduced 4.56%
8,030 $1.48 Million
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $46,070 - $61,616
-962 Reduced 10.26%
8,414 $1.61 Million
Q4 2018

Feb 12, 2019

SELL
$46.41 - $56.94 $18,424 - $22,605
-397 Reduced 4.06%
9,376 $1.44 Million
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $18,051 - $22,921
395 Added 4.21%
9,773 $1.7 Million
Q2 2018

Aug 02, 2018

SELL
$42.45 - $51.3 $8,574 - $10,362
-202 Reduced 2.11%
9,378 $1.37 Million
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $6,768 - $8,635
-182 Reduced 1.86%
9,580 $1.34 Million
Q4 2017

Feb 09, 2018

SELL
$33.79 - $39.39 $26,727 - $31,157
-791 Reduced 7.5%
9,762 $1.1 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $382,968 - $409,772
10,553
10,553 $1.15 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.